Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in

Di Chen1,2,3, Yangmin Ma4, Peiqi Li5

  • 1Shaanxi Key Laboratory of Chemical Additives for Industry, Shaanxi University of Science and Technology, Xi'an 710021, China. observercd@163.com.

Insights

Piperlongumine (PL) and doxorubicin (DOX) synergistically inhibit triple-negative breast cancer (TNBC) growth by inducing apoptosis. This combination therapy targets the JAK2-STAT3 pathway, offering a promising strategy for TNBC treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Triple-negative breast cancer (TNBC) lacks targeted therapies, with chemotherapy like doxorubicin (DOX) offering limited efficacy and significant side effects.
  • Piperlongumine (PL), a natural alkaloid, exhibits selective anticancer properties and presents a potential new strategy for TNBC.
  • The JAK2-STAT3 pathway is implicated in cancer progression and represents a potential therapeutic target.

Purpose of the Study:

  • To evaluate the efficacy of piperlongumine (PL) and doxorubicin (DOX) alone and in combination against TNBC.
  • To elucidate the underlying molecular mechanisms, specifically the role of the JAK2-STAT3 pathway.
  • To assess the therapeutic potential of PL-DOX combination in a preclinical TNBC model.

Main Methods:

  • Cell viability and colony formation assays were used to assess growth inhibition.
  • Flow cytometry was employed to analyze apoptosis induction.
  • Western blot analysis was performed to investigate protein expression and pathway activation.
  • A tumor xenograft model was utilized to evaluate in vivo efficacy.

Main Results:

  • Piperlongumine (PL) demonstrated significant inhibition of TNBC cell growth and induced apoptosis.
  • The combination of PL and DOX exhibited synergistic effects, enhancing growth suppression and apoptosis induction in TNBC cells.
  • PL, alone or in combination with DOX, suppressed the activation of the JAK2-STAT3 pathway.
  • The combination therapy showed significant efficacy in reducing tumor volume in the xenograft model.

Conclusions:

  • The combination of piperlongumine (PL) and doxorubicin (DOX) demonstrates synergistic anticancer activity against triple-negative breast cancer (TNBC).
  • Inhibition of the JAK2-STAT3 pathway is a key mechanism underlying the efficacy of this combination therapy.
  • PL combined with chemotherapy represents a promising therapeutic strategy for clinical application in TNBC treatment.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K